Please login to the form below

Not currently logged in
Email:
Password:

Ogilvy PR adds to senior health team

Three of the New York office’s six new hires have been recruited to the healthcare team

Ogilvy PR Kara GolubOgilvy Public Relations has announced several senior hires, including three to its healthcare practice.

Kara Golub, Linda Ruckel and Christopher Wahlers – all vice presidents – have already stepped into their new roles at the integrated communications firm.

Golub (pictured top right) joined Ogilvy from Ruder Finn, where she implemented high-profile consumer campaigns, data and regulatory announcements, and social media initiatives. In her new role, she will provide strategic communications counsel for a range of clients, including Boehringer Ingelheim.

Ogilvy PR Linda RuckelRuckel (pictured left) has been recruited to support the Agency for Healthcare Research and Quality on partnership development and dissemination of treatment options information. She was previously vice president in MSLGroup's health and medical centre practice.

Wahlers (pictured bottom right) specialises in developing strategic planning and programming. He left MWW Group for Ogilvy – also a vice president with the former, he created and managed campaigns for Deloitte Life Services Health Care.

Ogilvy PR Chris Wahlers

The recruitment spree was prompted by 'incremental growth, involving both new and existing clients, in the healthcare group', an Ogilvy spokesperson told PMLiVE. The agency is still hiring, and has several openings, she said.

1st October 2013

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics